HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer
Y Luo, Z Yang, Y Yu, P Zhang - International Journal of Biological …, 2022 - Elsevier
Prostate cancer (PCa) is one of the most prevalent malignancies in adult males. However,
PCa is resistant to multi-kinase inhibitors-based anti-angiogenic therapies, and the …
PCa is resistant to multi-kinase inhibitors-based anti-angiogenic therapies, and the …
HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer.
Y Luo, Z Yang, Y Yu, P Zhang - International Journal of Biological …, 2022 - europepmc.org
Prostate cancer (PCa) is one of the most prevalent malignancies in adult males. However,
PCa is resistant to multi-kinase inhibitors-based anti-angiogenic therapies, and the …
PCa is resistant to multi-kinase inhibitors-based anti-angiogenic therapies, and the …
HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer
Y Luo, Z Yang, Y Yu, P Zhang - International journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the most prevalent malignancies in adult males. However,
PCa is resistant to multi-kinase inhibitors-based anti-angiogenic therapies, and the …
PCa is resistant to multi-kinase inhibitors-based anti-angiogenic therapies, and the …